| MCHUTCHINSON, John G, Zachary D GOODMAN, Hala R MAKLOUF, Maribel RODRIGUEZ-TORRES, Mitchell L SHIFFMAN, Don C ROCKEY, Petr HUSA a Wan-Long, et al. CHUANG. Double blind, randomized, placebo-controlled, multi-center, phase II dose ranging study to assess the antifibrotic activity of farglitazar in chronic hepatitis C infection. Hepatology. Philadelphia: W.B.Saunders Company, roč. 48, 4 Suppl., s. 1139-1140. ISSN 0270-9139. 2008. |
Další formáty:
BibTeX
LaTeX
RIS
@article{791409,
author = {McHutchinson, John G and Goodman, Zachary D and Maklouf, Hala R and RodriguezandTorres, Maribel and Shiffman, Mitchell L and Rockey, Don C and Husa, Petr and Chuang, WanandLong, et al.},
article_location = {Philadelphia},
article_number = {4 Suppl.},
language = {eng},
issn = {0270-9139},
journal = {Hepatology},
title = {Double blind, randomized, placebo-controlled, multi-center, phase II dose ranging study to assess the antifibrotic activity of farglitazar in chronic hepatitis C infection.},
volume = {48},
year = {2008}
}
TY - JOUR
ID - 791409
AU - McHutchinson, John G - Goodman, Zachary D - Maklouf, Hala R - Rodriguez-Torres, Maribel - Shiffman, Mitchell L - Rockey, Don C - Husa, Petr - Chuang, Wan-Long, et al.
PY - 2008
TI - Double blind, randomized, placebo-controlled, multi-center, phase II dose ranging study to assess the antifibrotic activity of farglitazar in chronic hepatitis C infection.
JF - Hepatology
VL - 48
IS - 4 Suppl.
SP - 1139
EP - 1139
PB - W.B.Saunders Company
SN - 02709139
ER -
MCHUTCHINSON, John G, Zachary D GOODMAN, Hala R MAKLOUF, Maribel RODRIGUEZ-TORRES, Mitchell L SHIFFMAN, Don C ROCKEY, Petr HUSA a Wan-Long, et al. CHUANG. Double blind, randomized, placebo-controlled, multi-center, phase II dose ranging study to assess the antifibrotic activity of farglitazar in chronic hepatitis C infection. \textit{Hepatology}. Philadelphia: W.B.Saunders Company, roč.~48, 4 Suppl., s.~1139-1140. ISSN~0270-9139. 2008.
|
